Brief: Simcere Pharmaceutical Announce Issuance Of First Prescription For COSELA(Trilaciclib) In China
09/02/2023 15:57
Feb 9 (Reuters) - Simcere Pharmaceutical Group Ltd
2096.HK :
* SIMCERE PHARMACEUTICAL - CO, G1 THERAPEUTICS ANNOUNCE
ISSUANCE
OF FIRST PRESCRIPTION FOR COSELA(TRILACICLIB) IN CHINA
Source text for Eikon: ID:nPnbDbtPga
Further company coverage: 2096.HK
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660